Department of Endodontics, Faculty of Dentistry, Universitat Internacional de Catalunya, Barcelona, Spain.
Department of Clinical Sciences, College of Dentistry, Ajman University, Ajman, United Arab Emirates.
Int Endod J. 2021 Nov;54(11):2086-2098. doi: 10.1111/iej.13603. Epub 2021 Sep 1.
To develop a formulation in which calcium hydroxide (Ca(OH)₂) was successfully loaded into poly(lactic-co-glycolic acid) (PLGA) biodegradable nanoparticles (NPs) to be used in the field of endodontics as an intracanal medicament, including NP optimization and characterization, plus drug release profile of the NPs compared with free Ca(OH)₂. Additionally, the depth and area of penetration of the NPs inside the dentinal tubules of extracted teeth were compared with those of the free Ca(OH)₂.
Ca(OH)₂ NPs were prepared using the solvent displacement method. NPs was optimized with a central composite design to obtain a final optimized formulation. The morphology of the NPs was examined under transmission electron microscopy (TEM), and characterization was carried out using X-ray diffraction (XRD), Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The drug release profile of the Ca(OH)₂ NPs and free Ca(OH)₂ was evaluated up to 48 h. Finally, the depth and area of penetration inside the dentinal tubules of extracted teeth were examined for both the Ca(OH)₂ NPs and free Ca(OH)₂ using the Mann-Whitney U test to determine any significant differences.
Utilizing the optimized formulation, the Ca(OH)₂ NPs had an average size below 200 nm and polydispersity index lower than 0.2, along with a highly negative zeta potential and suitable entrapment efficiency percentage. The spherical morphology of the Ca(OH)₂ NPs was confirmed using TEM. The results of the XRD, FTIR and DSC revealed no interactions and confirmed that the drug was encapsulated inside the NPs. The drug release profile of the Ca(OH)₂ NPs exhibited a prolonged steady release that remained stable up to 48 h with higher concentrations than the free Ca(OH)₂. After examination by confocal laser scanning microscopy, Ca(OH)₂ NPs had a significantly greater depth and area of penetration inside dentinal tubules compared with the free drug.
Ca(OH)₂-loaded PLGA NPs were successfully optimized and characterized. The NPs exhibited a prolonged drug release profile and superior penetration inside dentinal tubules of extracted teeth when compared to Ca(OH) .
将氢氧化钙(Ca(OH)₂)成功载入聚乳酸-羟基乙酸共聚物(PLGA)可生物降解纳米颗粒(NPs)中,用作牙髓腔内药物,包括 NP 优化和特性分析,以及与游离 Ca(OH)₂相比的 NPs 药物释放曲线。此外,还比较了 NPs 和游离 Ca(OH)₂在离体牙牙本质小管内的渗透深度和面积。
采用溶剂置换法制备 Ca(OH)₂ NPs。采用中心复合设计对 NPs 进行优化,以获得最终优化配方。通过透射电子显微镜(TEM)观察 NPs 的形态,通过 X 射线衍射(XRD)、傅里叶变换红外(FTIR)和差示扫描量热法(DSC)进行特性分析。评估 Ca(OH)₂ NPs 和游离 Ca(OH)₂的药物释放曲线,最长达 48 小时。最后,采用曼-惠特尼 U 检验比较游离 Ca(OH)₂和 Ca(OH)₂ NPs 在离体牙牙本质小管内的渗透深度和面积,以确定是否存在显著差异。
利用优化的配方,Ca(OH)₂ NPs 的平均粒径小于 200nm,多分散指数低于 0.2,具有高负 zeta 电位和合适的包封效率百分比。TEM 证实 Ca(OH)₂ NPs 的形态为球形。XRD、FTIR 和 DSC 的结果表明没有相互作用,证实药物被包裹在 NPs 内。Ca(OH)₂ NPs 的药物释放曲线呈延长的稳定释放,在 48 小时内保持稳定,浓度高于游离 Ca(OH)₂。通过共聚焦激光扫描显微镜检查,Ca(OH)₂ NPs 在牙本质小管内的渗透深度和面积明显大于游离药物。
成功优化和表征了负载 Ca(OH)₂的 PLGA NPs。与游离药物相比,NPs 表现出延长的药物释放曲线和更优异的牙本质小管内渗透性能。